Sameer Chopra

Company: Werewolf Therapeutics

Job title: Vice President, Clinical Development

Seminars:

Tumor-activated INDUKINE Molecules: Improving the Therapeutic Index of Proinflammatory Cytokines for Cancer Immunotherapy 4:15 pm

Illustrating the concept, design and preclinical validation of tumor-activated IL-2 and IL-12 INDUKINE molecules Demonstrating that a prodrug strategy permits systemic dosing of wild type cytokines at exposures required for monotherapy activity Integrating clinical safety, efficacy, PK and tumor biomarker data to establish POC for novel cytokine engineering strategies in FIH studiesRead more

day: Conference Day One